Expression of Cytochrome P450 in non-small cell lung cancer

Frontiers in Bioscience

Volumn 13, Issue 15, 2008, Pages 5787-5793

  Oyama, Tsunehiro ^a,b   Sugio, Kenji ^a   Isse, Toyohi ^b   Matsumoto, Akiko ^c   Nose, Naohiro ^a   Uramoto, Hidetaka ^a   Nozoe, Tadahiro ^a   Morita, Masaru ^d   Kagawa, Norio ^e   Osaki, Toshihiro ^f   Muto, Manabu ^g   Yasumoto, Kosei ^a   Kawamoto, Toshihiro ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e SAARLAND UNIVERSITY   (Germany)

^f ASO IIZUKA HOSPITAL   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anticancer drug; Anticancer prodrug; Aromatase; Cytochrome P450; Non small cell lung cancer (NSCLC); Review; Vitamin D

Indexed keywords

AROMATASE; COLECALCIFEROL; CYTOCHROME P450; STEROID MONOOXYGENASE; VITAMIN D 24 HYDROXYLASE; VITAMIN D 24-HYDROXYLASE;

ENZYMOLOGY; FEMALE; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; REVIEW; SMOKING;

AROMATASE; CARCINOMA, NON-SMALL-CELL LUNG; CHOLECALCIFEROL; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; SMOKING; STEROID HYDROXYLASES;

EID: 44649131477     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3116     Document Type: Article

References (44)

1. Oyama, T., K. Sugio, H. Uramoto, T. Kawamoto, N. Kagawa, S. Nadaf, D. Carbone & K. Yasumoto: Cytochrome P450 expression (CYP) in non-small cell lung cancer. Front Biosci, 12, 2299-308 (2007)
2. Brambilla, E., W. D. Travis, T. V. Colby, B. Corrin & Y. Shimosato: The new World Health Organization classification of lung tumours. Eur Respir J, 18, 1059-68 (2001) (Pubitemid 34092881)
3. Zhang, W., W. D. Shannon, J. Duncan, G. L. Scheffer, R. J. Scheper & H. L. McLeod: Expression of drug pathway proteins is independent of tumour type. J Pathol, 209, 213-9 (2006) (Pubitemid 43805417)
4. Murray, G. I.: The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol, 192, 419-26 (2000)
5. Oyama, T., N. Kagawa, N. Kunugita, K. Kitagawa, M. Ogawa, T. Yamaguchi, R. Suzuki, T. Kinaga, Y. Yashima, S. Ozaki, T. Isse, Y. D. Kim, H. Kim & T. Kawamoto: Expression of cytochrome P450 in tumor tissues and its association with cancer development. Front Biosci, 9, 1967-76 (2004) (Pubitemid 38918646)
6. Gharavi, N. & A. O. El-Kadi: Expression of cytochrome P450 in lung tumor. Curr Drug Metab, 5, 203-10 (2004) (Pubitemid 38515248)
7. Czerwinski, M., T. L. McLemore, H. V. Gelboin & F. J. Gonzalez: Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res, 54, 1085-91 (1994) (Pubitemid 24085467)
8. Toussaint, C., N. Albin, L. Massaad, D. Grunenwald, O. Parise, Jr., J. Morizet, A. Gouyette & G. G. Chabot: Main drug-and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Cancer Res, 53, 4608-12 (1993) (Pubitemid 23304387)
9. Chang, J. T., H. Chang, P. H. Chen, S. L. Lin & P. Lin: Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res, 13, 38-45 (2007) (Pubitemid 46121850)
10. McLemore, T.L., S. Adelberg, M. C. Liu, N. A. McMahon, S. J. Yu, W. C. Hubbard, M. Czerwinski, T. G. Wood, R. Storeng, R. A. Lubet, J. C. Eggleston, M. R. Boyd, R. & N. Hines: Expression of CYP1A1 gene in patients with lung cancer: evidence for cigarette smokeinduced gene expression in normal lung tissue and for altered gene regulation in primary pulmonary carcinomas. J Natl Cancer Inst, 82, 1333-9 (1990) (Pubitemid 20238488)
11. Spivack, S. D., G. J. Hurteau, M. J. Fasco & L. S. Kaminsky: Phase I and II carcinogen metabolism gene expression in human lung tissue and tumors. Clin Cancer Res, 9, 6002-11 (2003) (Pubitemid 38018087)
12. Spivack, S. D., G. J. Hurteau, A. A. Reilly, K. M. Aldous, X. Ding & L. S. Kaminsky: CYP1B1 expression in human lung. Drug Metab Dispos, 29, 916-22 (2001) (Pubitemid 32488651)
13. Lin, P., H. Chang, W. L. Ho, M. H. Wu & J. M. Su: Association of aryl hydrocarbon receptor and cytochrome P4501B1 expressions in human non-small cell lung cancers. Lung Cancer, 42, 255-61 (2003) (Pubitemid 37468537)
14. Kushida, H., K. Fujita, A. Suzuki, M. Yamada, T. Endo, T. Nohmi & T. Kamataki: Metabolic activation of Nalkylnitrosamines in genetically engineered Salmonella typhimurium expressing CYP2E1 or CYP2A6 together with human NADPH-cytochrome P450 reductase. Carcinogenesis, 21, 1227-32 (2000) (Pubitemid 30389351)
15. Albano, E., P. Clot, M. Morimoto, A. Tomasi, M. Ingelman-Sundberg & S. W. French: Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology, 23, 155-63 (1996) (Pubitemid 26012104)
16. Kivisto, K. T., A. Linder, G. Friedel, P. Beaune, C. Belloc, H. K. Kroemer & P. Fritz: Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue. Virchows Arch, 426, 243-7 (1995)
17. Raunio, H., J. Hakkola, J. Hukkanen, O. Pelkonen, R. Edwards, A. Boobis & S. Anttila: Expression of xenobiotic-metabolizing cytochrome P450s in human pulmonary tissues. Arch Toxicol Suppl, 20, 465-9 (1998)
18. Kivisto, K. T., H. K. Kroemer & M. Eichelbaum: The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions. Br J Clin Pharmacol, 40, 523-30 (1995) (Pubitemid 26005556)
19. Guengerich, F. P.: Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol, 39, 1-17 (1999) (Pubitemid 29222549)
20. Kivisto, K. T., E. U. Griese, P. Fritz, A. Linder, J. Hakkola, H. Raunio, P. Beaune & H. K. Kroemer: Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. Naunyn Schmiedebergs Arch Pharmacol, 353, 207-12 (1996)
21. Kivisto, K. T., P. Fritz, A. Linder, G. Friedel, P. Beaune & H. K. Kroemer: Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue. Histochem Cell Biol, 103, 25-9 (1995)
22. Anttila, S., J. Hukkanen, J. Hakkola, T. Stjernvall, P. Beaune, R. J. Edwards, A. R. Boobis, O. Pelkonen & H. Raunio: Expression and localization of CYP3A4 and CYP3A5 in human lung. Am J Respir Cell Mol Biol, 16, 242-9 (1997) (Pubitemid 127497446)
23. Hukkanen, J., O. Pelkonen, J. Hakkola & H. Raunio: Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol, 32, 391-411 (2002) (Pubitemid 35191358)
24. Piipari, R., K. Savela, T. Nurminen, J. Hukkanen, H. Raunio, J. Hakkola, T. Mantyla, P. Beaune, R. J. Edwards, A. R. Boobis & S. Anttila: Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers. Int J Cancer, 86, 610-6 (2000) (Pubitemid 30249869)
25. Piipari, R., T. Nurminen, K. Savela, A. Hirvonen, T. Mantyla & S. Anttila: Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages. Lung Cancer, 39, 265-72 (2003) (Pubitemid 36279446)
26. Tychopoulos, M., L. Corcos, P. Genne, P. Beaune & I. de Waziers: A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein. Cancer Gene Ther, 12, 497-508 (2005) (Pubitemid 40629340)
27. Coscio, A. M. & J. Garst: Lung cancer in women. Curr Oncol Rep, 8, 248-51 (2006) (Pubitemid 43970975)
28. Patrone, C., T. N. Cassel, K. Pettersson, Y. S. Piao, G. Cheng, P. Ciana, A. Maggi, M. Warner, J. A. Gustafsson & M. Nord: Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol, 23, 8542-52 (2003) (Pubitemid 37441291)
29. Pietras, R. J., D. C. Marquez, H. W. Chen, E. Tsai, O. Weinberg & M. Fishbein: Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids, 70, 372-81 (2005) (Pubitemid 40616035)
30. Oyama, T., M. Morita, T. Isse, N. Kagawa, S. Nakata, T. So, M. Mizukami, Y. Ichiki, K. Ono, M. Sugaya, H. Uramoto, T. Yoshimatsu, T. Hanagiri, K. Sugio, T. Kawamoto & K. Yasumoto: Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Front Biosci, 10, 1156-61 (2005)
31. Weinberg, O. K., D. C. Marquez-Garban, M. C. Fishbein, L. Goodglick, H. J. Garban, S. M. Dubinett & R. J. Pietras: Aromatase inhibitors in human lung cancer therapy. Cancer Res, 65, 11287-91 (2005) (Pubitemid 41821684)
32. Kagawa, N., H. Hori, M. R. Waterman & S. Yoshioka: Characterization of stable human aromatase expressed in E. coli. Steroids, 69, 235-43 (2004) (Pubitemid 38748719)
33. Mah, V., D. B. Seligson, A. Li, D. C. Marquez, Wistuba, II, Y. Elshimali, M. C. Fishbein, D. Chia, R. J. Pietras & L. Goodglick: Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res, 67, 10484-90 (2007) (Pubitemid 350070824)
34. Osborne, C. K.: Tamoxifen in the treatment of breast cancer. N Engl J Med, 339, 1609-18 (1998) (Pubitemid 28536137)
35. Fisher, B., J. P. Costantino, D. L. Wickerham, R. S. Cecchini, W. M. Cronin, A. Robidoux, T. B. Bevers, M. T. Kavanah, J. N. Atkins, R. G. Margolese, C. D. Runowicz, J. M. James, L. G. Ford & N. Wolmark: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst, 97, 1652-62 (2005) (Pubitemid 41672231)
36. Shibutani, S., P. M. Shaw, N. Suzuki, L. Dasaradhi, M. W. Duffel & I. Terashima: Sulfation of alphahydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts. Carcinogenesis, 19, 2007-11 (1998) (Pubitemid 28521945)
37. Parise, R. A., M. J. Egorin, B. Kanterewicz, M. Taimi, M. Petkovich, A. M. Lew, S. S. Chuang, M. Nichols, T. El-Hefnawy & P. A. Hershberger: CYP24, the enzyme that catabolizes the antiproliferative agent vitamin D, is increased in lung cancer. Int J Cancer, 119, 1819-28 (2006) (Pubitemid 44356838)
38. Anderson, M. G., M. Nakane, X. Ruan, P. E. Kroeger & J. R. Wu-Wong: Expression of VDR and CYP24A1 mRNA in human tumors. Cancer Chemother Pharmacol, 57, 234-40 (2006) (Pubitemid 41779843)
39. Sawada, N., T. Sakaki, S. Kitanaka, S. Kato & K. Inouye: Structure-function analysis of CYP27B1 and CYP27A1. Studies on mutants from patients with vitamin D-dependent rickets type I (VDDR-I) and cerebrotendinous xanthomatosis (CTX). Eur J Biochem, 268, 6607-15 (2001) (Pubitemid 34014768)
40. Uchida, E., N. Kagawa, T. Sakaki, N. Urushino, N. Sawada, M. Kamakura, M. Ohta, S. Kato & K. Inouye: Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES. Biochem Biophys Res Commun, 323, 505-11 (2004) (Pubitemid 39221126)
41. Yamamoto, K., E. Uchida, N. Urushino, T. Sakaki, N. Kagawa, N. Sawada, M. Kamakura, S. Kato, K. Inouye & S. Yamada: Identification of the amino acid residue of CYP27B1 responsible for binding of 25-hydroxyvitamin D3 whose mutation causes vitamin D-dependent rickets type 1. J Biol Chem, 280, 30511-6 (2005) (Pubitemid 41216235)
42. Urushino, N., K. Yamamoto, N. Kagawa, S. Ikushiro, M. Kamakura, S. Yamada, S. Kato, K. Inouye & T. Sakaki: Interaction between mitochondrial CYP27B1 and adrenodoxin: role of arginine 458 of mouse CYP27B1. Biochemistry, 45, 4405-12 (2006)
43. Sakaki, T., N. Sawada, K. Komai, S. Shiozawa, S. Yamada, K. Yamamoto, Y. Ohyama & K. Inouye: Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24. Eur J Biochem, 267, 6158-65 (2000)
44. Sakaki, T., N. Kagawa, K. Yamamoto & K. Inouye: Metabolism of vitamin D3 by cytochromes P450. Front Biosci, 10, 119-34 (2005)